{"id":454256,"date":"2019-12-06T01:50:01","date_gmt":"2019-12-06T01:50:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=454256"},"modified":"2019-12-06T01:50:01","modified_gmt":"2019-12-06T01:50:01","slug":"intravenous-iron-drugs-market-future-demand-market-analysis-outlook-20192026-grand-view-research-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/intravenous-iron-drugs-market-future-demand-market-analysis-outlook-20192026-grand-view-research-inc_454256.html","title":{"rendered":"Intravenous Iron Drugs Market Future Demand, Market Analysis & Outlook 2019-2026: Grand View Research, Inc"},"content":{"rendered":"
\"Intravenous<\/a><\/p>\n
\n
Grand View Research, Inc. \u2013 Market Research And Consulting<\/div>\n<\/div>\n<\/div>\n
In 2018, North America accounted for the largest market share due to the increasing application of intravenous iron drugs in cancer research, increasing adoption of low cost & compact intravenous iron drugs in clinical diagnostics, and infrastructural development of research laboratories.<\/div>\n

The global intravenous (IV) iron drugs market<\/strong> size is expected to reach USD 2.90 billion by 2026,expanding at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research. Growing prevalence of chronic diseases, noncompliance of oral drug treatment and recent approvals of novel products are the key factors driving the IV iron drugs market. However, some of the factors that are restraining the market include the adverse side effects, stringent regulations, availability of nutraceutical alternatives, and complex approval process.<\/p>\n

Iron is one of the crucial components in the hemoglobin and plays an important role in the transportation of oxygen throughout the body. It also takes part in several biological processes such as energy metabolism, formation of collagen, the synthesis of heme, formation of myoglobin, immune system functions, and neurotransmitter production. Around 30% of anemia in women and children in developing nations is caused by deficiency of iron according to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017. Growing cases of chronic kidney diseases, iron deficiency anemia in gastroenterology, gynecology and oncology and growing cohort with high rate of unresponsive oral therapy is expected to drive the demand for these drugs. Furthermore, increasing healthcare expenditure and high accuracy, sensitivity and easy access of intravenous iron drugs fuels the market growth.<\/p>\n

Among the products, the ferric carboxymaltose segment dominated the global intravenous iron drugs market in 2018 and is expected to grow significantly due to its increasing application in drug discovery processes, superior performance, and reduced cost. Ferric carboxymaltose is marketed as Injectafer in North America and under the name of Ferinject outside North America. Asia Pacific is projected to demonstrate the highest CAGR during the forecast period, while North America held the largest market share in 2018.<\/p>\n

“Read Report Summary, Toc, Market Segmentation, Research Methodology, Request a Free Sample“ Intravenous Iron Drugs Market Click the link below:
<\/strong><\/strong>www.grandviewresearch.com\/industry-analysis\/intravenous-iron-drugs-market<\/strong><\/a><\/p>\n

\"North<\/strong><\/p>\n

 <\/p>\n

Request a Free Sample Report Intravenous Iron Drugs Market” Click the link below:
www.grandviewresearch.com\/industry-analysis\/intravenous-iron-drugs-market\/request\/rs1<\/a>
<\/strong><\/strong><\/strong><\/p>\n

Further Key Findings From the Study Suggest:<\/span><\/span><\/strong><\/p>\n